Qinghua Qiao

TL;DR: The laboratory findings of 1,850 patients are analyzed to describe the dynamic changes of the total antibody, spike protein (S)-, receptor-binding domain (RBD)-, and nucleoprotein (N)-specific immunoglobulin M (IGM) and G (IgG) levels during SARS-CoV-2 infection and recovery.

TL;DR: In this paper, the role of interleukin-6 (IL-6) levels during SARS-CoV-2 infection was investigated and two specific treatments, namely, tocilizumab and convalescent plasma therapy (CPT), decreased the level of IL-6 and relieved inflammation.

TL;DR: Preliminary experience shows that patients with AIRD tend to have a higher risk of SARS-CoV-2 infection, and may be at risk for a severe but less likely critical disease course, and further investigation is needed to understand the immunological features of these diseases.

TL;DR: Two cases of patients with COVID-19-associated recurrent diarrhea and positive fecal occult blood who successfully recovered after a one-time convalescent plasma administration are presented.

TL;DR: Wang et al. as discussed by the authors investigated the relationship between lymphocytes subsets with the cytokine interleukin-6 (IL-6) and the characteristics of lymphocyte subsets in single-cell RNA sequencing (scRNA-seq) data obtained from peripheral blood mononuclear cells (PBMCs) in COVID-19 patients.